Cannell Capital TSCAN THERAPEUTICS INC ownership

TSCAN THERAPEUTICS INC's ticker is and the CUSIP is 89854M101. A total of 29 filers reported holding TSCAN THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.9%.

Cannell Capital ownership history of TSCAN THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$22,732
+50415.6%
14,6660.0%0.01%
-50.0%
Q3 2022$45
+309.1%
14,666
+301.4%
0.01%
+400.0%
Q2 2022$113,6540.00%